調査レポート | • レポートコード：QYR2104Z2243 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、勃起不全のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ED治療薬、ED用装置）、用途別市場規模（先天性患者、病的患者）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・勃起不全の市場動向 ・企業の競争状況、市場シェア ・勃起不全の種類別市場規模（ED治療薬、ED用装置） ・勃起不全の用途別市場規模（先天性患者、病的患者） ・勃起不全の北米市場規模2016-2027（アメリカ、カナダ） ・勃起不全のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・勃起不全のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・勃起不全の中南米市場規模2016-2027（メキシコ、ブラジル） ・勃起不全の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly、Pfizer、Bayer、Boston Scientific、Coloplast、Apricus Biosciences、Cristalia Produtos Quimicos Farmaceuticos、Dong-A Socio、Endo Pharmaceuticals、Futura Medical、Meda Pharmaceuticals、Promedon、SK Chemical、Teva Pharmaceuticals、Vivus、Zephyr Surgical Implants (ZSI)） ・結論 |
The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels.
The ED drugs segment led the market and accounted for almost 80% of the market share in terms of revenue.
Market Analysis and Insights: Global Erectile Dysfunction Market
The global Erectile Dysfunction market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Erectile Dysfunction market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Erectile Dysfunction market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Erectile Dysfunction market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Erectile Dysfunction market.
Global Erectile Dysfunction Scope and Market Size
Erectile Dysfunction market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Erectile Dysfunction market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
ED Drugs
ED Devices
Segment by Application
Congenital Patients
Pathological Patients
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Eli Lilly
Pfizer
Bayer
Boston Scientific
Coloplast
Apricus Biosciences
Cristalia Produtos Quimicos Farmaceuticos
Dong-A Socio
Endo Pharmaceuticals
Boston Scientific
Coloplast
Promedon
SK Chemical
Teva Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Erectile Dysfunction Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ED Drugs
1.2.3 ED Devices
1.3 Market by Application
1.3.1 Global Erectile Dysfunction Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Congenital Patients
1.3.3 Pathological Patients
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Erectile Dysfunction Market Perspective (2016-2027)
2.2 Erectile Dysfunction Growth Trends by Regions
2.2.1 Erectile Dysfunction Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Erectile Dysfunction Historic Market Share by Regions (2016-2021)
2.2.3 Erectile Dysfunction Forecasted Market Size by Regions (2022-2027)
2.3 Erectile Dysfunction Industry Dynamic
2.3.1 Erectile Dysfunction Market Trends
2.3.2 Erectile Dysfunction Market Drivers
2.3.3 Erectile Dysfunction Market Challenges
2.3.4 Erectile Dysfunction Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Erectile Dysfunction Players by Revenue
3.1.1 Global Top Erectile Dysfunction Players by Revenue (2016-2021)
3.1.2 Global Erectile Dysfunction Revenue Market Share by Players (2016-2021)
3.2 Global Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Erectile Dysfunction Revenue
3.4 Global Erectile Dysfunction Market Concentration Ratio
3.4.1 Global Erectile Dysfunction Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Erectile Dysfunction Revenue in 2020
3.5 Erectile Dysfunction Key Players Head office and Area Served
3.6 Key Players Erectile Dysfunction Product Solution and Service
3.7 Date of Enter into Erectile Dysfunction Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Erectile Dysfunction Breakdown Data by Type
4.1 Global Erectile Dysfunction Historic Market Size by Type (2016-2021)
4.2 Global Erectile Dysfunction Forecasted Market Size by Type (2022-2027)
5 Erectile Dysfunction Breakdown Data by Application
5.1 Global Erectile Dysfunction Historic Market Size by Application (2016-2021)
5.2 Global Erectile Dysfunction Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Erectile Dysfunction Market Size (2016-2027)
6.2 North America Erectile Dysfunction Market Size by Type
6.2.1 North America Erectile Dysfunction Market Size by Type (2016-2021)
6.2.2 North America Erectile Dysfunction Market Size by Type (2022-2027)
6.2.3 North America Erectile Dysfunction Market Size by Type (2016-2027)
6.3 North America Erectile Dysfunction Market Size by Application
6.3.1 North America Erectile Dysfunction Market Size by Application (2016-2021)
6.3.2 North America Erectile Dysfunction Market Size by Application (2022-2027)
6.3.3 North America Erectile Dysfunction Market Size by Application (2016-2027)
6.4 North America Erectile Dysfunction Market Size by Country
6.4.1 North America Erectile Dysfunction Market Size by Country (2016-2021)
6.4.2 North America Erectile Dysfunction Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Erectile Dysfunction Market Size (2016-2027)
7.2 Europe Erectile Dysfunction Market Size by Type
7.2.1 Europe Erectile Dysfunction Market Size by Type (2016-2021)
7.2.2 Europe Erectile Dysfunction Market Size by Type (2022-2027)
7.2.3 Europe Erectile Dysfunction Market Size by Type (2016-2027)
7.3 Europe Erectile Dysfunction Market Size by Application
7.3.1 Europe Erectile Dysfunction Market Size by Application (2016-2021)
7.3.2 Europe Erectile Dysfunction Market Size by Application (2022-2027)
7.3.3 Europe Erectile Dysfunction Market Size by Application (2016-2027)
7.4 Europe Erectile Dysfunction Market Size by Country
7.4.1 Europe Erectile Dysfunction Market Size by Country (2016-2021)
7.4.2 Europe Erectile Dysfunction Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Erectile Dysfunction Market Size (2016-2027)
8.2 Asia-Pacific Erectile Dysfunction Market Size by Type
8.2.1 Asia-Pacific Erectile Dysfunction Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Erectile Dysfunction Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Erectile Dysfunction Market Size by Type (2016-2027)
8.3 Asia-Pacific Erectile Dysfunction Market Size by Application
8.3.1 Asia-Pacific Erectile Dysfunction Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Erectile Dysfunction Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Erectile Dysfunction Market Size by Application (2016-2027)
8.4 Asia-Pacific Erectile Dysfunction Market Size by Region
8.4.1 Asia-Pacific Erectile Dysfunction Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Erectile Dysfunction Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Erectile Dysfunction Market Size (2016-2027)
9.2 Latin America Erectile Dysfunction Market Size by Type
9.2.1 Latin America Erectile Dysfunction Market Size by Type (2016-2021)
9.2.2 Latin America Erectile Dysfunction Market Size by Type (2022-2027)
9.2.3 Latin America Erectile Dysfunction Market Size by Type (2016-2027)
9.3 Latin America Erectile Dysfunction Market Size by Application
9.3.1 Latin America Erectile Dysfunction Market Size by Application (2016-2021)
9.3.2 Latin America Erectile Dysfunction Market Size by Application (2022-2027)
9.3.3 Latin America Erectile Dysfunction Market Size by Application (2016-2027)
9.4 Latin America Erectile Dysfunction Market Size by Country
9.4.1 Latin America Erectile Dysfunction Market Size by Country (2016-2021)
9.4.2 Latin America Erectile Dysfunction Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Erectile Dysfunction Market Size (2016-2027)
10.2 Middle East & Africa Erectile Dysfunction Market Size by Type
10.2.1 Middle East & Africa Erectile Dysfunction Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Erectile Dysfunction Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Erectile Dysfunction Market Size by Type (2016-2027)
10.3 Middle East & Africa Erectile Dysfunction Market Size by Application
10.3.1 Middle East & Africa Erectile Dysfunction Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Erectile Dysfunction Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Erectile Dysfunction Market Size by Application (2016-2027)
10.4 Middle East & Africa Erectile Dysfunction Market Size by Country
10.4.1 Middle East & Africa Erectile Dysfunction Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Erectile Dysfunction Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Erectile Dysfunction Introduction
11.1.4 Eli Lilly Revenue in Erectile Dysfunction Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Erectile Dysfunction Introduction
11.2.4 Pfizer Revenue in Erectile Dysfunction Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Erectile Dysfunction Introduction
11.3.4 Bayer Revenue in Erectile Dysfunction Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 Boston Scientific
11.4.1 Boston Scientific Company Details
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific Erectile Dysfunction Introduction
11.4.4 Boston Scientific Revenue in Erectile Dysfunction Business (2016-2021)
11.4.5 Boston Scientific Recent Development
11.5 Coloplast
11.5.1 Coloplast Company Details
11.5.2 Coloplast Business Overview
11.5.3 Coloplast Erectile Dysfunction Introduction
11.5.4 Coloplast Revenue in Erectile Dysfunction Business (2016-2021)
11.5.5 Coloplast Recent Development
11.6 Apricus Biosciences
11.6.1 Apricus Biosciences Company Details
11.6.2 Apricus Biosciences Business Overview
11.6.3 Apricus Biosciences Erectile Dysfunction Introduction
11.6.4 Apricus Biosciences Revenue in Erectile Dysfunction Business (2016-2021)
11.6.5 Apricus Biosciences Recent Development
11.7 Cristalia Produtos Quimicos Farmaceuticos
11.7.1 Cristalia Produtos Quimicos Farmaceuticos Company Details
11.7.2 Cristalia Produtos Quimicos Farmaceuticos Business Overview
11.7.3 Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Introduction
11.7.4 Cristalia Produtos Quimicos Farmaceuticos Revenue in Erectile Dysfunction Business (2016-2021)
11.7.5 Cristalia Produtos Quimicos Farmaceuticos Recent Development
11.8 Dong-A Socio
11.8.1 Dong-A Socio Company Details
11.8.2 Dong-A Socio Business Overview
11.8.3 Dong-A Socio Erectile Dysfunction Introduction
11.8.4 Dong-A Socio Revenue in Erectile Dysfunction Business (2016-2021)
11.8.5 Dong-A Socio Recent Development
11.9 Endo Pharmaceuticals
11.9.1 Endo Pharmaceuticals Company Details
11.9.2 Endo Pharmaceuticals Business Overview
11.9.3 Endo Pharmaceuticals Erectile Dysfunction Introduction
11.9.4 Endo Pharmaceuticals Revenue in Erectile Dysfunction Business (2016-2021)
11.9.5 Endo Pharmaceuticals Recent Development
11.10 Futura Medical
11.10.1 Futura Medical Company Details
11.10.2 Futura Medical Business Overview
11.10.3 Futura Medical Erectile Dysfunction Introduction
11.10.4 Futura Medical Revenue in Erectile Dysfunction Business (2016-2021)
11.10.5 Futura Medical Recent Development
11.11 Meda Pharmaceuticals
11.11.1 Meda Pharmaceuticals Company Details
11.11.2 Meda Pharmaceuticals Business Overview
11.11.3 Meda Pharmaceuticals Erectile Dysfunction Introduction
11.11.4 Meda Pharmaceuticals Revenue in Erectile Dysfunction Business (2016-2021)
11.11.5 Meda Pharmaceuticals Recent Development
11.12 Promedon
11.12.1 Promedon Company Details
11.12.2 Promedon Business Overview
11.12.3 Promedon Erectile Dysfunction Introduction
11.12.4 Promedon Revenue in Erectile Dysfunction Business (2016-2021)
11.12.5 Promedon Recent Development
11.13 SK Chemical
11.13.1 SK Chemical Company Details
11.13.2 SK Chemical Business Overview
11.13.3 SK Chemical Erectile Dysfunction Introduction
11.13.4 SK Chemical Revenue in Erectile Dysfunction Business (2016-2021)
11.13.5 SK Chemical Recent Development
11.14 Teva Pharmaceuticals
11.14.1 Teva Pharmaceuticals Company Details
11.14.2 Teva Pharmaceuticals Business Overview
11.14.3 Teva Pharmaceuticals Erectile Dysfunction Introduction
11.14.4 Teva Pharmaceuticals Revenue in Erectile Dysfunction Business (2016-2021)
11.14.5 Teva Pharmaceuticals Recent Development
11.15 Vivus
11.15.1 Vivus Company Details
11.15.2 Vivus Business Overview
11.15.3 Vivus Erectile Dysfunction Introduction
11.15.4 Vivus Revenue in Erectile Dysfunction Business (2016-2021)
11.15.5 Vivus Recent Development
11.16 Zephyr Surgical Implants (ZSI)
11.16.1 Zephyr Surgical Implants (ZSI) Company Details
11.16.2 Zephyr Surgical Implants (ZSI) Business Overview
11.16.3 Zephyr Surgical Implants (ZSI) Erectile Dysfunction Introduction
11.16.4 Zephyr Surgical Implants (ZSI) Revenue in Erectile Dysfunction Business (2016-2021)
11.16.5 Zephyr Surgical Implants (ZSI) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Erectile Dysfunction Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ED Drugs
Table 3. Key Players of ED Devices
Table 4. Global Erectile Dysfunction Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Erectile Dysfunction Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Erectile Dysfunction Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Erectile Dysfunction Market Share by Regions (2016-2021)
Table 8. Global Erectile Dysfunction Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Erectile Dysfunction Market Share by Regions (2022-2027)
Table 10. Erectile Dysfunction Market Trends
Table 11. Erectile Dysfunction Market Drivers
Table 12. Erectile Dysfunction Market Challenges
Table 13. Erectile Dysfunction Market Restraints
Table 14. Global Erectile Dysfunction Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Erectile Dysfunction Market Share by Players (2016-2021)
Table 16. Global Top Erectile Dysfunction Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erectile Dysfunction as of 2020)
Table 17. Ranking of Global Top Erectile Dysfunction Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Erectile Dysfunction Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Erectile Dysfunction Product Solution and Service
Table 21. Date of Enter into Erectile Dysfunction Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Erectile Dysfunction Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Erectile Dysfunction Revenue Market Share by Type (2016-2021)
Table 25. Global Erectile Dysfunction Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Erectile Dysfunction Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Erectile Dysfunction Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Erectile Dysfunction Revenue Market Share by Application (2016-2021)
Table 29. Global Erectile Dysfunction Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Erectile Dysfunction Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Erectile Dysfunction Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Erectile Dysfunction Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Erectile Dysfunction Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Erectile Dysfunction Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Erectile Dysfunction Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Erectile Dysfunction Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Erectile Dysfunction Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Erectile Dysfunction Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Erectile Dysfunction Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Erectile Dysfunction Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Erectile Dysfunction Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Erectile Dysfunction Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Erectile Dysfunction Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Erectile Dysfunction Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Erectile Dysfunction Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Erectile Dysfunction Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Erectile Dysfunction Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Erectile Dysfunction Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Erectile Dysfunction Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Erectile Dysfunction Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Erectile Dysfunction Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Erectile Dysfunction Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Erectile Dysfunction Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Erectile Dysfunction Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Erectile Dysfunction Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Erectile Dysfunction Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Erectile Dysfunction Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Erectile Dysfunction Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Erectile Dysfunction Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Erectile Dysfunction Market Size by Country (2022-2027) & (US$ Million)
Table 61. Eli Lilly Company Details
Table 62. Eli Lilly Business Overview
Table 63. Eli Lilly Erectile Dysfunction Product
Table 64. Eli Lilly Revenue in Erectile Dysfunction Business (2016-2021) & (US$ Million)
Table 65. Eli Lilly Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Erectile Dysfunction Product
Table 69. Pfizer Revenue in Erectile Dysfunction Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Bayer Company Details
Table 72. Bayer Business Overview
Table 73. Bayer Erectile Dysfunction Product
Table 74. Bayer Revenue in Erectile Dysfunction Business (2016-2021) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Boston Scientific Company Details
Table 77. Boston Scientific Business Overview
Table 78. Boston Scientific Erectile Dysfunction Product
Table 79. Boston Scientific Revenue in Erectile Dysfunction Business (2016-2021) & (US$ Million)
Table 80. Boston Scientific Recent Development
Table 81. Coloplast Company Details
Table 82. Coloplast Business Overview
Table 83. Coloplast Erectile Dysfunction Product
Table 84. Coloplast Revenue in Erectile Dysfunction Business (2016-2021) & (US$ Million)
Table 85. Coloplast Recent Development
Table 86. Apricus Biosciences Company Details
Table 87. Apricus Biosciences Business Overview
Table 88. Apricus Biosciences Erectile Dysfunction Product
Table 89. Apricus Biosciences Revenue in Erectile Dysfunction Business (2016-2021) & (US$ Million)
Table 90. Apricus Biosciences Recent Development
Table 91. Cristalia Produtos Quimicos Farmaceuticos Company Details
Table 92. Cristalia Produtos Quimicos Farmaceuticos Business Overview
Table 93. Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Product
Table 94. Cristalia Produtos Quimicos Farmaceuticos Revenue in Erectile Dysfunction Business (2016-2021) & (US$ Million)
Table 95. Cristalia Produtos Quimicos Farmaceuticos Recent Development
Table 96. Dong-A Socio Company Details
Table 97. Dong-A Socio Business Overview
Table 98. Dong-A Socio Revenue in Erectile Dysfunction Business (2016-2021) & (US$ Million)
Table 99. Dong-A Socio Recent Development
Table 100. Endo Pharmaceuticals Company Details
Table 101. Endo Pharmaceuticals Business Overview
Table 102. Endo Pharmaceuticals Erectile Dysfunction Product
Table 103. Endo Pharmaceuticals Revenue in Erectile Dysfunction Business (2016-2021) & (US$ Million)
Table 104. Endo Pharmaceuticals Recent Development
Table 105. Futura Medical Company Details
Table 106. Futura Medical Business Overview
Table 107. Futura Medical Erectile Dysfunction Product
Table 108. Futura Medical Revenue in Erectile Dysfunction Business (2016-2021) & (US$ Million)
Table 109. Futura Medical Recent Development
Table 110. Meda Pharmaceuticals Company Details
Table 111. Meda Pharmaceuticals Business Overview
Table 112. Meda Pharmaceuticals Erectile Dysfunction Product
Table 113. Meda Pharmaceuticals Revenue in Erectile Dysfunction Business (2016-2021) & (US$ Million)
Table 114. Meda Pharmaceuticals Recent Development
Table 115. Promedon Company Details
Table 116. Promedon Business Overview
Table 117. Promedon Erectile Dysfunction Product
Table 118. Promedon Revenue in Erectile Dysfunction Business (2016-2021) & (US$ Million)
Table 119. Promedon Recent Development
Table 120. SK Chemical Company Details
Table 121. SK Chemical Business Overview
Table 122. SK Chemical Erectile Dysfunction Product
Table 123. SK Chemical Revenue in Erectile Dysfunction Business (2016-2021) & (US$ Million)
Table 124. SK Chemical Recent Development
Table 125. Teva Pharmaceuticals Company Details
Table 126. Teva Pharmaceuticals Business Overview
Table 127. Teva Pharmaceuticals Erectile Dysfunction Product
Table 128. Teva Pharmaceuticals Revenue in Erectile Dysfunction Business (2016-2021) & (US$ Million)
Table 129. Teva Pharmaceuticals Recent Development
Table 130. Vivus Company Details
Table 131. Vivus Business Overview
Table 132. Vivus Erectile Dysfunction Product
Table 133. Vivus Revenue in Erectile Dysfunction Business (2016-2021) & (US$ Million)
Table 134. Vivus Recent Development
Table 135. Zephyr Surgical Implants (ZSI) Company Details
Table 136. Zephyr Surgical Implants (ZSI) Business Overview
Table 137. Zephyr Surgical Implants (ZSI) Erectile Dysfunction Product
Table 138. Zephyr Surgical Implants (ZSI) Revenue in Erectile Dysfunction Business (2016-2021) & (US$ Million)
Table 139. Zephyr Surgical Implants (ZSI) Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Erectile Dysfunction Market Share by Type: 2020 VS 2027
Figure 2. ED Drugs Features
Figure 3. ED Devices Features
Figure 4. Global Erectile Dysfunction Market Share by Application: 2020 VS 2027
Figure 5. Congenital Patients Case Studies
Figure 6. Pathological Patients Case Studies
Figure 7. Erectile Dysfunction Report Years Considered
Figure 8. Global Erectile Dysfunction Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Erectile Dysfunction Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Erectile Dysfunction Market Share by Regions: 2020 VS 2027
Figure 11. Global Erectile Dysfunction Market Share by Regions (2022-2027)
Figure 12. Global Erectile Dysfunction Market Share by Players in 2020
Figure 13. Global Top Erectile Dysfunction Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erectile Dysfunction as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Erectile Dysfunction Revenue in 2020
Figure 15. Global Erectile Dysfunction Revenue Market Share by Type (2016-2021)
Figure 16. Global Erectile Dysfunction Revenue Market Share by Type (2022-2027)
Figure 17. North America Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Erectile Dysfunction Market Share by Type (2016-2027)
Figure 19. North America Erectile Dysfunction Market Share by Application (2016-2027)
Figure 20. North America Erectile Dysfunction Market Share by Country (2016-2027)
Figure 21. United States Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Erectile Dysfunction Market Share by Type (2016-2027)
Figure 25. Europe Erectile Dysfunction Market Share by Application (2016-2027)
Figure 26. Europe Erectile Dysfunction Market Share by Country (2016-2027)
Figure 27. Germany Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Erectile Dysfunction Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Erectile Dysfunction Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Erectile Dysfunction Market Share by Region (2016-2027)
Figure 37. China Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Erectile Dysfunction Market Share by Type (2016-2027)
Figure 45. Latin America Erectile Dysfunction Market Share by Application (2016-2027)
Figure 46. Latin America Erectile Dysfunction Market Share by Country (2016-2027)
Figure 47. Mexico Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Erectile Dysfunction Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Erectile Dysfunction Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Erectile Dysfunction Market Share by Country (2016-2027)
Figure 53. Turkey Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Erectile Dysfunction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Eli Lilly Revenue Growth Rate in Erectile Dysfunction Business (2016-2021)
Figure 57. Pfizer Revenue Growth Rate in Erectile Dysfunction Business (2016-2021)
Figure 58. Bayer Revenue Growth Rate in Erectile Dysfunction Business (2016-2021)
Figure 59. Boston Scientific Revenue Growth Rate in Erectile Dysfunction Business (2016-2021)
Figure 60. Coloplast Revenue Growth Rate in Erectile Dysfunction Business (2016-2021)
Figure 61. Apricus Biosciences Revenue Growth Rate in Erectile Dysfunction Business (2016-2021)
Figure 62. Cristalia Produtos Quimicos Farmaceuticos Revenue Growth Rate in Erectile Dysfunction Business (2016-2021)
Figure 63. Dong-A Socio Revenue Growth Rate in Erectile Dysfunction Business (2016-2021)
Figure 64. Endo Pharmaceuticals Revenue Growth Rate in Erectile Dysfunction Business (2016-2021)
Figure 65. Futura Medical Revenue Growth Rate in Erectile Dysfunction Business (2016-2021)
Figure 66. Meda Pharmaceuticals Revenue Growth Rate in Erectile Dysfunction Business (2016-2021)
Figure 67. Promedon Revenue Growth Rate in Erectile Dysfunction Business (2016-2021)
Figure 68. SK Chemical Revenue Growth Rate in Erectile Dysfunction Business (2016-2021)
Figure 69. Teva Pharmaceuticals Revenue Growth Rate in Erectile Dysfunction Business (2016-2021)
Figure 70. Vivus Revenue Growth Rate in Erectile Dysfunction Business (2016-2021)
Figure 71. Zephyr Surgical Implants (ZSI) Revenue Growth Rate in Erectile Dysfunction Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の勃起不全市場 2021：企業別、地域別、種類・用途別 The Erectile Dysfunction market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…- 世界の勃起不全用装置市場 2021：企業別、地域別、種類・用途別 The Erectile Dysfunction Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の内皮機能障害市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Endothelial Dysfunction Market The global Endothelial Dysfunction market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…
- 世界の先天性心疾患市場規模・現状・予測（2021年-2027年） Congenital diseases are disorders in a newborn due to certain genetic factors (and sometimes in association with the environment) that often results in malformations or underdeveloped organs. Congenital Heart Diseases (CHD) results in malformed or undeveloped heart that presents in a newborn with br…
- 世界の患者介助用器具市場 2021：企業別、地域別、種類・用途別 The Patients Handling Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…